Company / Free Cash Flow
RIGEL PHARMACEUTICALS INC Free Cash Flow History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$74.2M
FY2022
5-year range
-$74.2M / $5.3M
FY2018-FY2022
Trend
-1513.2%
vs FY2021
Sector context
#94 of 194
Health Care
What the data says
Free Cash Flow changed -1513% YoY in FY2022, a notable deviation from the 6-year average annual change of -231%.
Based on SEC 10-K filings.
-$74M in FY2022.
Declined from -$53M to -$74M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#94 of 194 in Health CareTop 48% of 194This company -$74.2M Sector average $470.8M
▼
-115.8% below sector average
Key checks
Key Insights
- In FY2022, free cash flow decreased 1513.2% year-over-year.
- Ranks #94 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2021.
- Lowest free cash flow in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -$74.2M | -1513.2% |
| FY2021 | $5.3M | +109.8% |
| FY2020 | -$53.4M | -24.4% |
| FY2019 | -$43.0M | +44.0% |
| FY2018 | -$76.7M | +1.3% |
| FY2017 | -$77.7M | -1.3% |
| FY2016 | -$76.7M | -220.1% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026